1192109-69-5

Basic information

• Product Name: 2,2-Difluoro-cyclopropanecarbaldehyde
• Synonyms: 2,2-Difluoro-cyclopropanecarbaldehyde
• CAS NO: 1192109-69-5
• Molecular Formula: C₄H₄F₂O
• Molecular Weight: 106.0707664
• Mol File: 1192109-69-5.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 82.1±40.0 °C(Predicted)
• Appearance: /
• Density: 1.25±0.1 g/cm3(Predicted)
• CAS DataBase Reference: 2,2-Difluoro-cyclopropanecarbaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 2,2-Difluoro-cyclopropanecarbaldehyde(1192109-69-5)
• EPA Substance Registry System: 2,2-Difluoro-cyclopropanecarbaldehyde(1192109-69-5)

Safety Data

• Hazardous Substances Data: 1192109-69-5(Hazardous Substances Data)

Usage

General Description

2,2-Difluoro-cyclopropanecarbaldehyde is a chemical compound with the molecular formula C4H4F2O. It is a colorless liquid with a pungent odor and is primarily used in the synthesis of pharmaceuticals and agrochemicals. 2,2-Difluoro-cyclopropanecarbaldehyde is also utilized as an intermediate in the production of other organic compounds and as a reagent in research and industrial processes. 2,2-Difluoro-cyclopropanecarbaldehyde is considered to be a potentially hazardous chemical and should be handled with caution, as it can cause irritation to the eyes, skin, and respiratory system upon exposure.

Upstream product

• 509072-57-5 rac-(2,2-difluorocyclopropyl)methanol 

Relevant articles and documents

Substituted Oxopyridine Derivatives and Use Thereof in the Treatment of Cardiovascular Disorders

The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.

SUBSTITUTED OXOPYRIDINE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF CARDIOVASCULAR DISORDERS

The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.

5, 7-SUBSTITUTED-IMIDAZO [1, 2-C] PYRIMIDINES AS INHIBITORS OF JAK KINASES

Compounds of Formula I: (Formula should be inserted here) and stereoisomers and pharmaceutically acceptable salts and solvates thereof in which R1, R2, R3, R4, R5, R6, R7, X1 and X2 have the meanings given in the specification, are inhibitors of one or more JAK kinases and are useful in the treatment of autoimmune diseases, inflammatory diseases, rejection of transplanted organs, tissues and cells, as well as hematologic disorders and malignancies and their co-morbidities.